nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Glyburide—type 2 diabetes mellitus	0.0639	1	CbGbCtD
Zoledronate—GGPS1—retina—type 2 diabetes mellitus	0.00811	0.0843	CbGeAlD
Zoledronate—GGPS1—nephron tubule—type 2 diabetes mellitus	0.00763	0.0794	CbGeAlD
Zoledronate—GGPS1—cardiovascular system—type 2 diabetes mellitus	0.00686	0.0713	CbGeAlD
Zoledronate—GGPS1—kidney—type 2 diabetes mellitus	0.00671	0.0698	CbGeAlD
Zoledronate—GGPS1—cortex of kidney—type 2 diabetes mellitus	0.00653	0.068	CbGeAlD
Zoledronate—GGPS1—adipose tissue—type 2 diabetes mellitus	0.00605	0.0629	CbGeAlD
Zoledronate—FDPS—islet of Langerhans—type 2 diabetes mellitus	0.00437	0.0455	CbGeAlD
Zoledronate—GGPS1—liver—type 2 diabetes mellitus	0.00424	0.0441	CbGeAlD
Zoledronate—FDPS—nephron tubule—type 2 diabetes mellitus	0.00352	0.0366	CbGeAlD
Zoledronate—FDPS—cardiovascular system—type 2 diabetes mellitus	0.00316	0.0329	CbGeAlD
Zoledronate—CA12—kidney—type 2 diabetes mellitus	0.00313	0.0325	CbGeAlD
Zoledronate—FDPS—kidney—type 2 diabetes mellitus	0.00309	0.0322	CbGeAlD
Zoledronate—FDPS—pancreas—type 2 diabetes mellitus	0.00307	0.032	CbGeAlD
Zoledronate—FDPS—cortex of kidney—type 2 diabetes mellitus	0.00301	0.0313	CbGeAlD
Zoledronate—FDPS—adipose tissue—type 2 diabetes mellitus	0.00279	0.029	CbGeAlD
Zoledronate—CA14—liver—type 2 diabetes mellitus	0.00253	0.0264	CbGeAlD
Zoledronate—CA2—islet of Langerhans—type 2 diabetes mellitus	0.00227	0.0236	CbGeAlD
Zoledronate—FDPS—liver—type 2 diabetes mellitus	0.00195	0.0203	CbGeAlD
Zoledronate—CA2—retina—type 2 diabetes mellitus	0.00194	0.0202	CbGeAlD
Zoledronate—CA2—nephron tubule—type 2 diabetes mellitus	0.00183	0.019	CbGeAlD
Zoledronate—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.00175	0.0182	CbGeAlD
Zoledronate—CA2—cardiovascular system—type 2 diabetes mellitus	0.00164	0.0171	CbGeAlD
Zoledronate—ABCC1—adipose tissue—type 2 diabetes mellitus	0.00162	0.0168	CbGeAlD
Zoledronate—CA2—kidney—type 2 diabetes mellitus	0.00161	0.0167	CbGeAlD
Zoledronate—CA2—pancreas—type 2 diabetes mellitus	0.0016	0.0166	CbGeAlD
Zoledronate—CA2—cortex of kidney—type 2 diabetes mellitus	0.00156	0.0163	CbGeAlD
Zoledronate—CA2—adipose tissue—type 2 diabetes mellitus	0.00145	0.015	CbGeAlD
Zoledronate—Risedronate—PTGS2—type 2 diabetes mellitus	0.00119	0.529	CrCbGaD
Zoledronate—ABCC1—liver—type 2 diabetes mellitus	0.00114	0.0118	CbGeAlD
Zoledronate—Clodronate—PTGS2—type 2 diabetes mellitus	0.00106	0.471	CrCbGaD
Zoledronate—CA2—liver—type 2 diabetes mellitus	0.00101	0.0106	CbGeAlD
Zoledronate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000255	0.000454	CcSEcCtD
Zoledronate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000255	0.000453	CcSEcCtD
Zoledronate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000255	0.000453	CcSEcCtD
Zoledronate—Vertigo—Losartan—type 2 diabetes mellitus	0.000255	0.000453	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000255	0.000453	CcSEcCtD
Zoledronate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000254	0.000453	CcSEcCtD
Zoledronate—Somnolence—Valsartan—type 2 diabetes mellitus	0.000254	0.000452	CcSEcCtD
Zoledronate—Syncope—Losartan—type 2 diabetes mellitus	0.000254	0.000452	CcSEcCtD
Zoledronate—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000254	0.000451	CcSEcCtD
Zoledronate—Leukopenia—Losartan—type 2 diabetes mellitus	0.000254	0.000451	CcSEcCtD
Zoledronate—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000253	0.00045	CcSEcCtD
Zoledronate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000253	0.00045	CcSEcCtD
Zoledronate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000252	0.000448	CcSEcCtD
Zoledronate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000252	0.000448	CcSEcCtD
Zoledronate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000252	0.000448	CcSEcCtD
Zoledronate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000252	0.000447	CcSEcCtD
Zoledronate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000251	0.000446	CcSEcCtD
Zoledronate—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000251	0.000446	CcSEcCtD
Zoledronate—Palpitations—Losartan—type 2 diabetes mellitus	0.00025	0.000445	CcSEcCtD
Zoledronate—Nausea—Glimepiride—type 2 diabetes mellitus	0.00025	0.000444	CcSEcCtD
Zoledronate—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000249	0.000443	CcSEcCtD
Zoledronate—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000249	0.000443	CcSEcCtD
Zoledronate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000249	0.000442	CcSEcCtD
Zoledronate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000249	0.000442	CcSEcCtD
Zoledronate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000249	0.000442	CcSEcCtD
Zoledronate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000249	0.000442	CcSEcCtD
Zoledronate—Anorexia—Metformin—type 2 diabetes mellitus	0.000248	0.000441	CcSEcCtD
Zoledronate—Cough—Losartan—type 2 diabetes mellitus	0.000247	0.00044	CcSEcCtD
Zoledronate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000247	0.00044	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000247	0.000439	CcSEcCtD
Zoledronate—Alopecia—Ramipril—type 2 diabetes mellitus	0.000247	0.000439	CcSEcCtD
Zoledronate—Fatigue—Valsartan—type 2 diabetes mellitus	0.000247	0.000438	CcSEcCtD
Zoledronate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000246	0.000437	CcSEcCtD
Zoledronate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000246	0.000437	CcSEcCtD
Zoledronate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000246	0.000437	CcSEcCtD
Zoledronate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000246	0.000437	CcSEcCtD
Zoledronate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000246	0.000437	CcSEcCtD
Zoledronate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000245	0.000436	CcSEcCtD
Zoledronate—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000245	0.000435	CcSEcCtD
Zoledronate—Constipation—Valsartan—type 2 diabetes mellitus	0.000245	0.000435	CcSEcCtD
Zoledronate—Infection—Irbesartan—type 2 diabetes mellitus	0.000244	0.000434	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000244	0.000434	CcSEcCtD
Zoledronate—Fatigue—Orlistat—type 2 diabetes mellitus	0.000244	0.000433	CcSEcCtD
Zoledronate—Hypotension—Metformin—type 2 diabetes mellitus	0.000243	0.000433	CcSEcCtD
Zoledronate—Erythema—Ramipril—type 2 diabetes mellitus	0.000243	0.000432	CcSEcCtD
Zoledronate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000243	0.000432	CcSEcCtD
Zoledronate—Shock—Irbesartan—type 2 diabetes mellitus	0.000242	0.00043	CcSEcCtD
Zoledronate—Pain—Orlistat—type 2 diabetes mellitus	0.000242	0.00043	CcSEcCtD
Zoledronate—Arthralgia—Losartan—type 2 diabetes mellitus	0.000241	0.000429	CcSEcCtD
Zoledronate—Chest pain—Losartan—type 2 diabetes mellitus	0.000241	0.000429	CcSEcCtD
Zoledronate—Myalgia—Losartan—type 2 diabetes mellitus	0.000241	0.000429	CcSEcCtD
Zoledronate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000241	0.000429	CcSEcCtD
Zoledronate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000241	0.000428	CcSEcCtD
Zoledronate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000241	0.000428	CcSEcCtD
Zoledronate—Anxiety—Losartan—type 2 diabetes mellitus	0.00024	0.000427	CcSEcCtD
Zoledronate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00024	0.000426	CcSEcCtD
Zoledronate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000239	0.000425	CcSEcCtD
Zoledronate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000239	0.000425	CcSEcCtD
Zoledronate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000239	0.000424	CcSEcCtD
Zoledronate—Discomfort—Losartan—type 2 diabetes mellitus	0.000238	0.000424	CcSEcCtD
Zoledronate—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000238	0.000423	CcSEcCtD
Zoledronate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000238	0.000422	CcSEcCtD
Zoledronate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000238	0.000422	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000237	0.000422	CcSEcCtD
Zoledronate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000237	0.000422	CcSEcCtD
Zoledronate—Dry mouth—Losartan—type 2 diabetes mellitus	0.000236	0.00042	CcSEcCtD
Zoledronate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000234	0.000416	CcSEcCtD
Zoledronate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000234	0.000416	CcSEcCtD
Zoledronate—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000234	0.000416	CcSEcCtD
Zoledronate—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000234	0.000415	CcSEcCtD
Zoledronate—Confusional state—Losartan—type 2 diabetes mellitus	0.000233	0.000415	CcSEcCtD
Zoledronate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000233	0.000414	CcSEcCtD
Zoledronate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000232	0.000413	CcSEcCtD
Zoledronate—Somnolence—Metformin—type 2 diabetes mellitus	0.000231	0.000412	CcSEcCtD
Zoledronate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000231	0.000411	CcSEcCtD
Zoledronate—Oedema—Losartan—type 2 diabetes mellitus	0.000231	0.000411	CcSEcCtD
Zoledronate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000231	0.000411	CcSEcCtD
Zoledronate—Infection—Losartan—type 2 diabetes mellitus	0.00023	0.000409	CcSEcCtD
Zoledronate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00023	0.000408	CcSEcCtD
Zoledronate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000229	0.000408	CcSEcCtD
Zoledronate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000229	0.000408	CcSEcCtD
Zoledronate—Tremor—Ramipril—type 2 diabetes mellitus	0.000228	0.000405	CcSEcCtD
Zoledronate—Shock—Losartan—type 2 diabetes mellitus	0.000228	0.000405	CcSEcCtD
Zoledronate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000227	0.000404	CcSEcCtD
Zoledronate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000227	0.000403	CcSEcCtD
Zoledronate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000226	0.000403	CcSEcCtD
Zoledronate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000226	0.000402	CcSEcCtD
Zoledronate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000226	0.000402	CcSEcCtD
Zoledronate—Tachycardia—Losartan—type 2 diabetes mellitus	0.000226	0.000401	CcSEcCtD
Zoledronate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000225	0.000401	CcSEcCtD
Zoledronate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000225	0.0004	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000225	0.0004	CcSEcCtD
Zoledronate—Fatigue—Metformin—type 2 diabetes mellitus	0.000224	0.000399	CcSEcCtD
Zoledronate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000224	0.000399	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000224	0.000398	CcSEcCtD
Zoledronate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000224	0.000398	CcSEcCtD
Zoledronate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000223	0.000397	CcSEcCtD
Zoledronate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000223	0.000397	CcSEcCtD
Zoledronate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000223	0.000397	CcSEcCtD
Zoledronate—Agitation—Ramipril—type 2 diabetes mellitus	0.000223	0.000397	CcSEcCtD
Zoledronate—Constipation—Metformin—type 2 diabetes mellitus	0.000223	0.000396	CcSEcCtD
Zoledronate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000222	0.000395	CcSEcCtD
Zoledronate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000221	0.000392	CcSEcCtD
Zoledronate—Anorexia—Losartan—type 2 diabetes mellitus	0.00022	0.000392	CcSEcCtD
Zoledronate—Vomiting—Glyburide—type 2 diabetes mellitus	0.00022	0.000392	CcSEcCtD
Zoledronate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00022	0.000392	CcSEcCtD
Zoledronate—Malaise—Ramipril—type 2 diabetes mellitus	0.000219	0.00039	CcSEcCtD
Zoledronate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000219	0.00039	CcSEcCtD
Zoledronate—Rash—Glyburide—type 2 diabetes mellitus	0.000219	0.000389	CcSEcCtD
Zoledronate—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000218	0.000388	CcSEcCtD
Zoledronate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000218	0.000388	CcSEcCtD
Zoledronate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000218	0.000388	CcSEcCtD
Zoledronate—Syncope—Ramipril—type 2 diabetes mellitus	0.000218	0.000387	CcSEcCtD
Zoledronate—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000217	0.000387	CcSEcCtD
Zoledronate—Headache—Glyburide—type 2 diabetes mellitus	0.000217	0.000386	CcSEcCtD
Zoledronate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000216	0.000385	CcSEcCtD
Zoledronate—Hypotension—Losartan—type 2 diabetes mellitus	0.000216	0.000384	CcSEcCtD
Zoledronate—Palpitations—Ramipril—type 2 diabetes mellitus	0.000215	0.000382	CcSEcCtD
Zoledronate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000215	0.000382	CcSEcCtD
Zoledronate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000214	0.00038	CcSEcCtD
Zoledronate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000214	0.00038	CcSEcCtD
Zoledronate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000213	0.000379	CcSEcCtD
Zoledronate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000213	0.000379	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000212	0.000377	CcSEcCtD
Zoledronate—Cough—Ramipril—type 2 diabetes mellitus	0.000212	0.000377	CcSEcCtD
Zoledronate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000212	0.000377	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000211	0.000375	CcSEcCtD
Zoledronate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000211	0.000375	CcSEcCtD
Zoledronate—Convulsion—Ramipril—type 2 diabetes mellitus	0.000211	0.000374	CcSEcCtD
Zoledronate—Pain—Irbesartan—type 2 diabetes mellitus	0.00021	0.000374	CcSEcCtD
Zoledronate—Constipation—Irbesartan—type 2 diabetes mellitus	0.00021	0.000374	CcSEcCtD
Zoledronate—Insomnia—Losartan—type 2 diabetes mellitus	0.000209	0.000372	CcSEcCtD
Zoledronate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000208	0.00037	CcSEcCtD
Zoledronate—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000208	0.000369	CcSEcCtD
Zoledronate—Urticaria—Metformin—type 2 diabetes mellitus	0.000207	0.000368	CcSEcCtD
Zoledronate—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000207	0.000368	CcSEcCtD
Zoledronate—Myalgia—Ramipril—type 2 diabetes mellitus	0.000207	0.000368	CcSEcCtD
Zoledronate—Chest pain—Ramipril—type 2 diabetes mellitus	0.000207	0.000368	CcSEcCtD
Zoledronate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000206	0.000367	CcSEcCtD
Zoledronate—Anxiety—Ramipril—type 2 diabetes mellitus	0.000206	0.000367	CcSEcCtD
Zoledronate—Nausea—Glyburide—type 2 diabetes mellitus	0.000206	0.000366	CcSEcCtD
Zoledronate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000206	0.000366	CcSEcCtD
Zoledronate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000206	0.000366	CcSEcCtD
Zoledronate—Somnolence—Losartan—type 2 diabetes mellitus	0.000206	0.000366	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000205	0.000365	CcSEcCtD
Zoledronate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000205	0.000365	CcSEcCtD
Zoledronate—Discomfort—Ramipril—type 2 diabetes mellitus	0.000204	0.000363	CcSEcCtD
Zoledronate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000204	0.000362	CcSEcCtD
Zoledronate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000203	0.00036	CcSEcCtD
Zoledronate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000202	0.00036	CcSEcCtD
Zoledronate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000202	0.00036	CcSEcCtD
Zoledronate—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000202	0.00036	CcSEcCtD
Zoledronate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000201	0.000357	CcSEcCtD
Zoledronate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000201	0.000357	CcSEcCtD
Zoledronate—Confusional state—Ramipril—type 2 diabetes mellitus	0.0002	0.000356	CcSEcCtD
Zoledronate—Pruritus—Orlistat—type 2 diabetes mellitus	0.0002	0.000355	CcSEcCtD
Zoledronate—Fatigue—Losartan—type 2 diabetes mellitus	0.000199	0.000355	CcSEcCtD
Zoledronate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000198	0.000353	CcSEcCtD
Zoledronate—Oedema—Ramipril—type 2 diabetes mellitus	0.000198	0.000353	CcSEcCtD
Zoledronate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000198	0.000352	CcSEcCtD
Zoledronate—Constipation—Losartan—type 2 diabetes mellitus	0.000198	0.000352	CcSEcCtD
Zoledronate—Pain—Losartan—type 2 diabetes mellitus	0.000198	0.000352	CcSEcCtD
Zoledronate—Rash—Gliclazide—type 2 diabetes mellitus	0.000196	0.000349	CcSEcCtD
Zoledronate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000196	0.000349	CcSEcCtD
Zoledronate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000196	0.000348	CcSEcCtD
Zoledronate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000195	0.000347	CcSEcCtD
Zoledronate—Shock—Ramipril—type 2 diabetes mellitus	0.000195	0.000347	CcSEcCtD
Zoledronate—Headache—Gliclazide—type 2 diabetes mellitus	0.000195	0.000347	CcSEcCtD
Zoledronate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000194	0.000346	CcSEcCtD
Zoledronate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000194	0.000345	CcSEcCtD
Zoledronate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000194	0.000345	CcSEcCtD
Zoledronate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000194	0.000345	CcSEcCtD
Zoledronate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000194	0.000344	CcSEcCtD
Zoledronate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000193	0.000344	CcSEcCtD
Zoledronate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000193	0.000342	CcSEcCtD
Zoledronate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000192	0.000341	CcSEcCtD
Zoledronate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000191	0.000339	CcSEcCtD
Zoledronate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000189	0.000336	CcSEcCtD
Zoledronate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000189	0.000336	CcSEcCtD
Zoledronate—Anorexia—Ramipril—type 2 diabetes mellitus	0.000189	0.000336	CcSEcCtD
Zoledronate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000187	0.000332	CcSEcCtD
Zoledronate—Asthenia—Metformin—type 2 diabetes mellitus	0.000187	0.000332	CcSEcCtD
Zoledronate—Hypotension—Ramipril—type 2 diabetes mellitus	0.000185	0.000329	CcSEcCtD
Zoledronate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000185	0.000329	CcSEcCtD
Zoledronate—Pruritus—Metformin—type 2 diabetes mellitus	0.000184	0.000328	CcSEcCtD
Zoledronate—Urticaria—Losartan—type 2 diabetes mellitus	0.000184	0.000327	CcSEcCtD
Zoledronate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000183	0.000325	CcSEcCtD
Zoledronate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000183	0.000325	CcSEcCtD
Zoledronate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000182	0.000323	CcSEcCtD
Zoledronate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000181	0.000322	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000181	0.000321	CcSEcCtD
Zoledronate—Rash—Valsartan—type 2 diabetes mellitus	0.00018	0.000321	CcSEcCtD
Zoledronate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00018	0.00032	CcSEcCtD
Zoledronate—Vomiting—Orlistat—type 2 diabetes mellitus	0.00018	0.000319	CcSEcCtD
Zoledronate—Insomnia—Ramipril—type 2 diabetes mellitus	0.000179	0.000319	CcSEcCtD
Zoledronate—Headache—Valsartan—type 2 diabetes mellitus	0.000179	0.000319	CcSEcCtD
Zoledronate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000178	0.000317	CcSEcCtD
Zoledronate—Rash—Orlistat—type 2 diabetes mellitus	0.000178	0.000317	CcSEcCtD
Zoledronate—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000178	0.000317	CcSEcCtD
Zoledronate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000178	0.000316	CcSEcCtD
Zoledronate—Headache—Orlistat—type 2 diabetes mellitus	0.000177	0.000315	CcSEcCtD
Zoledronate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000177	0.000314	CcSEcCtD
Zoledronate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000176	0.000313	CcSEcCtD
Zoledronate—Somnolence—Ramipril—type 2 diabetes mellitus	0.000176	0.000313	CcSEcCtD
Zoledronate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000175	0.00031	CcSEcCtD
Zoledronate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000174	0.000309	CcSEcCtD
Zoledronate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000172	0.000307	CcSEcCtD
Zoledronate—Dizziness—Metformin—type 2 diabetes mellitus	0.000172	0.000306	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000171	0.000304	CcSEcCtD
Zoledronate—Fatigue—Ramipril—type 2 diabetes mellitus	0.000171	0.000304	CcSEcCtD
Zoledronate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00017	0.000303	CcSEcCtD
Zoledronate—Nausea—Valsartan—type 2 diabetes mellitus	0.00017	0.000302	CcSEcCtD
Zoledronate—Constipation—Ramipril—type 2 diabetes mellitus	0.00017	0.000302	CcSEcCtD
Zoledronate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000168	0.000299	CcSEcCtD
Zoledronate—Nausea—Orlistat—type 2 diabetes mellitus	0.000168	0.000298	CcSEcCtD
Zoledronate—Asthenia—Losartan—type 2 diabetes mellitus	0.000166	0.000295	CcSEcCtD
Zoledronate—Vomiting—Metformin—type 2 diabetes mellitus	0.000166	0.000294	CcSEcCtD
Zoledronate—Rash—Metformin—type 2 diabetes mellitus	0.000164	0.000292	CcSEcCtD
Zoledronate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000164	0.000292	CcSEcCtD
Zoledronate—Pruritus—Losartan—type 2 diabetes mellitus	0.000164	0.000291	CcSEcCtD
Zoledronate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000163	0.000291	CcSEcCtD
Zoledronate—Headache—Metformin—type 2 diabetes mellitus	0.000163	0.00029	CcSEcCtD
Zoledronate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000162	0.000289	CcSEcCtD
Zoledronate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000162	0.000288	CcSEcCtD
Zoledronate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000158	0.000281	CcSEcCtD
Zoledronate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000158	0.00028	CcSEcCtD
Zoledronate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000157	0.000279	CcSEcCtD
Zoledronate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000157	0.000279	CcSEcCtD
Zoledronate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000156	0.000278	CcSEcCtD
Zoledronate—Rash—Irbesartan—type 2 diabetes mellitus	0.000155	0.000275	CcSEcCtD
Zoledronate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000155	0.000275	CcSEcCtD
Zoledronate—Nausea—Metformin—type 2 diabetes mellitus	0.000155	0.000275	CcSEcCtD
Zoledronate—Headache—Irbesartan—type 2 diabetes mellitus	0.000154	0.000274	CcSEcCtD
Zoledronate—Dizziness—Losartan—type 2 diabetes mellitus	0.000153	0.000272	CcSEcCtD
Zoledronate—Vomiting—Losartan—type 2 diabetes mellitus	0.000147	0.000261	CcSEcCtD
Zoledronate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000146	0.00026	CcSEcCtD
Zoledronate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000146	0.00026	CcSEcCtD
Zoledronate—Rash—Losartan—type 2 diabetes mellitus	0.000146	0.000259	CcSEcCtD
Zoledronate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000146	0.000259	CcSEcCtD
Zoledronate—Headache—Losartan—type 2 diabetes mellitus	0.000145	0.000258	CcSEcCtD
Zoledronate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000142	0.000253	CcSEcCtD
Zoledronate—Pruritus—Ramipril—type 2 diabetes mellitus	0.00014	0.000249	CcSEcCtD
Zoledronate—Nausea—Losartan—type 2 diabetes mellitus	0.000137	0.000244	CcSEcCtD
Zoledronate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000136	0.000241	CcSEcCtD
Zoledronate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000131	0.000233	CcSEcCtD
Zoledronate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000126	0.000224	CcSEcCtD
Zoledronate—Rash—Ramipril—type 2 diabetes mellitus	0.000125	0.000222	CcSEcCtD
Zoledronate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000125	0.000222	CcSEcCtD
Zoledronate—Headache—Ramipril—type 2 diabetes mellitus	0.000124	0.000221	CcSEcCtD
Zoledronate—Nausea—Ramipril—type 2 diabetes mellitus	0.000118	0.000209	CcSEcCtD
Zoledronate—ABCC1—Metabolism—HBA2—type 2 diabetes mellitus	9.38e-05	0.000341	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—G6PC—type 2 diabetes mellitus	9.38e-05	0.000341	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ND1—type 2 diabetes mellitus	9.38e-05	0.000341	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ENPP1—type 2 diabetes mellitus	9.38e-05	0.000341	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.38e-05	0.000341	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ADCY5—type 2 diabetes mellitus	9.19e-05	0.000334	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GPX1—type 2 diabetes mellitus	9.16e-05	0.000333	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GCGR—type 2 diabetes mellitus	9.08e-05	0.00033	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.01e-05	0.000327	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GNB3—type 2 diabetes mellitus	9.01e-05	0.000327	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HMOX1—type 2 diabetes mellitus	8.97e-05	0.000326	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CD36—type 2 diabetes mellitus	8.92e-05	0.000324	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PSMD6—type 2 diabetes mellitus	8.89e-05	0.000323	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SNAP25—type 2 diabetes mellitus	8.89e-05	0.000323	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SREBF1—type 2 diabetes mellitus	8.89e-05	0.000323	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CAT—type 2 diabetes mellitus	8.85e-05	0.000322	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPP2CA—type 2 diabetes mellitus	8.81e-05	0.00032	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC5A2—type 2 diabetes mellitus	8.79e-05	0.000319	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	8.74e-05	0.000318	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CTGF—type 2 diabetes mellitus	8.73e-05	0.000317	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	8.71e-05	0.000317	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GNB3—type 2 diabetes mellitus	8.69e-05	0.000316	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.69e-05	0.000316	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HMOX1—type 2 diabetes mellitus	8.65e-05	0.000314	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMGCR—type 2 diabetes mellitus	8.65e-05	0.000314	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOB—type 2 diabetes mellitus	8.6e-05	0.000312	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYTB—type 2 diabetes mellitus	8.58e-05	0.000312	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—OXCT1—type 2 diabetes mellitus	8.58e-05	0.000312	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAT—type 2 diabetes mellitus	8.54e-05	0.00031	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ADRA2A—type 2 diabetes mellitus	8.47e-05	0.000308	CbGpPWpGaD
Zoledronate—CA14—Metabolism—MTHFR—type 2 diabetes mellitus	8.45e-05	0.000307	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTM1—type 2 diabetes mellitus	8.36e-05	0.000304	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SRD5A1—type 2 diabetes mellitus	8.36e-05	0.000304	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	8.31e-05	0.000302	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARA—type 2 diabetes mellitus	8.29e-05	0.000301	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOB—type 2 diabetes mellitus	8.29e-05	0.000301	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—LPL—type 2 diabetes mellitus	8.21e-05	0.000298	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP2E1—type 2 diabetes mellitus	8.13e-05	0.000295	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTM1—type 2 diabetes mellitus	8.06e-05	0.000293	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC2A1—type 2 diabetes mellitus	8.04e-05	0.000292	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP1A2—type 2 diabetes mellitus	8.04e-05	0.000292	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ADCY5—type 2 diabetes mellitus	8.03e-05	0.000292	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AGT—type 2 diabetes mellitus	8.03e-05	0.000292	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GPX1—type 2 diabetes mellitus	8.01e-05	0.000291	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PCK1—type 2 diabetes mellitus	7.98e-05	0.00029	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD17B3—type 2 diabetes mellitus	7.97e-05	0.00029	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACACA—type 2 diabetes mellitus	7.97e-05	0.00029	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—STAR—type 2 diabetes mellitus	7.97e-05	0.00029	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	7.97e-05	0.00029	CbGpPWpGaD
Zoledronate—CA12—Metabolism—LPL—type 2 diabetes mellitus	7.91e-05	0.000287	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CALM1—type 2 diabetes mellitus	7.9e-05	0.000287	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOE—type 2 diabetes mellitus	7.87e-05	0.000286	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP3A4—type 2 diabetes mellitus	7.84e-05	0.000285	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CD36—type 2 diabetes mellitus	7.8e-05	0.000283	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOA1—type 2 diabetes mellitus	7.78e-05	0.000283	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TLE4—type 2 diabetes mellitus	7.76e-05	0.000282	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ADCY5—type 2 diabetes mellitus	7.75e-05	0.000281	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GPX1—type 2 diabetes mellitus	7.72e-05	0.00028	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC2A4—type 2 diabetes mellitus	7.71e-05	0.00028	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GCG—type 2 diabetes mellitus	7.71e-05	0.00028	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPP2CA—type 2 diabetes mellitus	7.7e-05	0.00028	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCC8—type 2 diabetes mellitus	7.64e-05	0.000278	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CBS—type 2 diabetes mellitus	7.64e-05	0.000278	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CD36—type 2 diabetes mellitus	7.52e-05	0.000273	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HK1—type 2 diabetes mellitus	7.47e-05	0.000271	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPP2CA—type 2 diabetes mellitus	7.43e-05	0.00027	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MTHFR—type 2 diabetes mellitus	7.39e-05	0.000268	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—COX2—type 2 diabetes mellitus	7.36e-05	0.000267	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC5A2—type 2 diabetes mellitus	7.36e-05	0.000267	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARA—type 2 diabetes mellitus	7.25e-05	0.000263	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA6—type 2 diabetes mellitus	7.23e-05	0.000263	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.22e-05	0.000262	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GCKR—type 2 diabetes mellitus	7.21e-05	0.000262	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MTHFR—type 2 diabetes mellitus	7.13e-05	0.000259	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD11B1—type 2 diabetes mellitus	7.11e-05	0.000258	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UCP3—type 2 diabetes mellitus	7.11e-05	0.000258	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UCP2—type 2 diabetes mellitus	7.11e-05	0.000258	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AGT—type 2 diabetes mellitus	7.02e-05	0.000255	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARA—type 2 diabetes mellitus	6.99e-05	0.000254	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ALDOB—type 2 diabetes mellitus	6.92e-05	0.000251	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CALM1—type 2 diabetes mellitus	6.9e-05	0.000251	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.89e-05	0.00025	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOE—type 2 diabetes mellitus	6.88e-05	0.00025	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.87e-05	0.00025	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARG—type 2 diabetes mellitus	6.86e-05	0.000249	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.84e-05	0.000248	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOA1—type 2 diabetes mellitus	6.8e-05	0.000247	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.78e-05	0.000246	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AGT—type 2 diabetes mellitus	6.77e-05	0.000246	CbGpPWpGaD
Zoledronate—CA14—Metabolism—INS—type 2 diabetes mellitus	6.72e-05	0.000244	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PCK1—type 2 diabetes mellitus	6.68e-05	0.000243	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CALM1—type 2 diabetes mellitus	6.66e-05	0.000242	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GNB3—type 2 diabetes mellitus	6.65e-05	0.000241	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.65e-05	0.000241	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOE—type 2 diabetes mellitus	6.63e-05	0.000241	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMOX1—type 2 diabetes mellitus	6.62e-05	0.00024	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SPRY2—type 2 diabetes mellitus	6.6e-05	0.00024	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.58e-05	0.000239	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOA1—type 2 diabetes mellitus	6.56e-05	0.000238	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.55e-05	0.000238	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAT—type 2 diabetes mellitus	6.53e-05	0.000237	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RBP4—type 2 diabetes mellitus	6.43e-05	0.000234	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.42e-05	0.000233	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOB—type 2 diabetes mellitus	6.34e-05	0.00023	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HK1—type 2 diabetes mellitus	6.26e-05	0.000227	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.25e-05	0.000227	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—type 2 diabetes mellitus	6.16e-05	0.000224	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—type 2 diabetes mellitus	6.16e-05	0.000224	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.12e-05	0.000222	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LPL—type 2 diabetes mellitus	6.05e-05	0.00022	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD3B2—type 2 diabetes mellitus	6.04e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GCKR—type 2 diabetes mellitus	6.04e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPA—type 2 diabetes mellitus	6.04e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—KCNJ11—type 2 diabetes mellitus	6.04e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC2A2—type 2 diabetes mellitus	6e-05	0.000218	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—type 2 diabetes mellitus	5.99e-05	0.000218	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ADCY5—type 2 diabetes mellitus	5.92e-05	0.000215	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPX1—type 2 diabetes mellitus	5.9e-05	0.000214	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3R1—type 2 diabetes mellitus	5.9e-05	0.000214	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NOS3—type 2 diabetes mellitus	5.9e-05	0.000214	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTR—type 2 diabetes mellitus	5.88e-05	0.000214	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—INS—type 2 diabetes mellitus	5.88e-05	0.000214	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.81e-05	0.000211	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDOB—type 2 diabetes mellitus	5.79e-05	0.00021	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—type 2 diabetes mellitus	5.78e-05	0.00021	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NAMPT—type 2 diabetes mellitus	5.77e-05	0.00021	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CD36—type 2 diabetes mellitus	5.75e-05	0.000209	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GCK—type 2 diabetes mellitus	5.73e-05	0.000208	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IAPP—type 2 diabetes mellitus	5.7e-05	0.000207	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.68e-05	0.000206	CbGpPWpGaD
Zoledronate—CA12—Metabolism—INS—type 2 diabetes mellitus	5.67e-05	0.000206	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.63e-05	0.000204	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC9A1—type 2 diabetes mellitus	5.59e-05	0.000203	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—type 2 diabetes mellitus	5.55e-05	0.000202	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.52e-05	0.000201	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.51e-05	0.0002	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.45e-05	0.000198	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—type 2 diabetes mellitus	5.45e-05	0.000198	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—type 2 diabetes mellitus	5.39e-05	0.000196	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALB—type 2 diabetes mellitus	5.39e-05	0.000196	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GLP1R—type 2 diabetes mellitus	5.39e-05	0.000196	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARA—type 2 diabetes mellitus	5.34e-05	0.000194	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HMGA1—type 2 diabetes mellitus	5.24e-05	0.00019	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—type 2 diabetes mellitus	5.2e-05	0.000189	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.18e-05	0.000188	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AGT—type 2 diabetes mellitus	5.18e-05	0.000188	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3R1—type 2 diabetes mellitus	5.15e-05	0.000187	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NOS3—type 2 diabetes mellitus	5.15e-05	0.000187	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PSMD6—type 2 diabetes mellitus	5.14e-05	0.000187	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SNAP25—type 2 diabetes mellitus	5.14e-05	0.000187	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CALM1—type 2 diabetes mellitus	5.09e-05	0.000185	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOE—type 2 diabetes mellitus	5.07e-05	0.000184	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC2A2—type 2 diabetes mellitus	5.03e-05	0.000183	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOA1—type 2 diabetes mellitus	5.01e-05	0.000182	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CYBA—type 2 diabetes mellitus	4.98e-05	0.000181	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	4.97e-05	0.000181	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NOS3—type 2 diabetes mellitus	4.97e-05	0.000181	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTR—type 2 diabetes mellitus	4.93e-05	0.000179	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CPT1A—type 2 diabetes mellitus	4.93e-05	0.000179	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NAMPT—type 2 diabetes mellitus	4.83e-05	0.000175	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CALCA—type 2 diabetes mellitus	4.81e-05	0.000175	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.8e-05	0.000174	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LIPC—type 2 diabetes mellitus	4.8e-05	0.000174	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HBA1—type 2 diabetes mellitus	4.8e-05	0.000174	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GCK—type 2 diabetes mellitus	4.8e-05	0.000174	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP11A1—type 2 diabetes mellitus	4.77e-05	0.000173	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—type 2 diabetes mellitus	4.71e-05	0.000171	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC9A1—type 2 diabetes mellitus	4.68e-05	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC2A1—type 2 diabetes mellitus	4.65e-05	0.000169	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CETP—type 2 diabetes mellitus	4.63e-05	0.000168	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS1—type 2 diabetes mellitus	4.58e-05	0.000166	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	4.55e-05	0.000165	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TCF7L2—type 2 diabetes mellitus	4.53e-05	0.000165	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC2A4—type 2 diabetes mellitus	4.46e-05	0.000162	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—type 2 diabetes mellitus	4.42e-05	0.00016	CbGpPWpGaD
Zoledronate—CA2—Metabolism—INS—type 2 diabetes mellitus	4.33e-05	0.000157	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.32e-05	0.000157	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SREBF1—type 2 diabetes mellitus	4.31e-05	0.000156	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SNAP25—type 2 diabetes mellitus	4.31e-05	0.000156	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PSMD6—type 2 diabetes mellitus	4.31e-05	0.000156	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CTGF—type 2 diabetes mellitus	4.23e-05	0.000154	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMGCR—type 2 diabetes mellitus	4.19e-05	0.000152	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.13e-05	0.00015	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.11e-05	0.000149	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.1e-05	0.000149	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—type 2 diabetes mellitus	3.97e-05	0.000144	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.94e-05	0.000143	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.89e-05	0.000141	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.89e-05	0.000141	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFBR2—type 2 diabetes mellitus	3.88e-05	0.000141	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.8e-05	0.000138	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NOS3—type 2 diabetes mellitus	3.8e-05	0.000138	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.8e-05	0.000138	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.78e-05	0.000137	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN2B—type 2 diabetes mellitus	3.76e-05	0.000136	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GCG—type 2 diabetes mellitus	3.73e-05	0.000136	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.73e-05	0.000136	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOB—type 2 diabetes mellitus	3.66e-05	0.000133	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LPL—type 2 diabetes mellitus	3.5e-05	0.000127	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	3.48e-05	0.000126	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ADCY5—type 2 diabetes mellitus	3.42e-05	0.000124	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PPP2CA—type 2 diabetes mellitus	3.28e-05	0.000119	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CCR5—type 2 diabetes mellitus	3.22e-05	0.000117	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GNB3—type 2 diabetes mellitus	3.22e-05	0.000117	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.22e-05	0.000117	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMOX1—type 2 diabetes mellitus	3.2e-05	0.000116	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAT—type 2 diabetes mellitus	3.16e-05	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—type 2 diabetes mellitus	3.15e-05	0.000114	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOB—type 2 diabetes mellitus	3.07e-05	0.000111	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIF1A—type 2 diabetes mellitus	3e-05	0.000109	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS2—type 2 diabetes mellitus	3e-05	0.000109	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—type 2 diabetes mellitus	2.98e-05	0.000108	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CALM1—type 2 diabetes mellitus	2.94e-05	0.000107	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOE—type 2 diabetes mellitus	2.93e-05	0.000106	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPL—type 2 diabetes mellitus	2.93e-05	0.000106	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOA1—type 2 diabetes mellitus	2.9e-05	0.000105	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADCY5—type 2 diabetes mellitus	2.87e-05	0.000104	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPX1—type 2 diabetes mellitus	2.86e-05	0.000104	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CD36—type 2 diabetes mellitus	2.78e-05	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.75e-05	9.98e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS2—type 2 diabetes mellitus	2.73e-05	9.92e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—type 2 diabetes mellitus	2.71e-05	9.85e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	2.64e-05	9.58e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS1—type 2 diabetes mellitus	2.62e-05	9.5e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	2.59e-05	9.4e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	2.51e-05	9.1e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—INS—type 2 diabetes mellitus	2.5e-05	9.1e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-05	8.95e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	2.46e-05	8.92e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	2.43e-05	8.82e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT2—type 2 diabetes mellitus	2.42e-05	8.79e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—type 2 diabetes mellitus	2.37e-05	8.61e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	2.3e-05	8.36e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—type 2 diabetes mellitus	2.28e-05	8.3e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS3—type 2 diabetes mellitus	2.2e-05	7.98e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	2.2e-05	7.98e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	2.14e-05	7.77e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—INS—type 2 diabetes mellitus	2.1e-05	7.62e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	2.01e-05	7.3e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	1.92e-05	6.99e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-05	6.68e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-05	6.68e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—type 2 diabetes mellitus	1.75e-05	6.35e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-05	6.11e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SRC—type 2 diabetes mellitus	1.62e-05	5.9e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	1.45e-05	5.28e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGFR—type 2 diabetes mellitus	1.42e-05	5.17e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—type 2 diabetes mellitus	1.09e-05	3.98e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—type 2 diabetes mellitus	1.01e-05	3.67e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	8.46e-06	3.07e-05	CbGpPWpGaD
